Trachomatis (CT) & Neisseria
Gonorrhoeae (NG)
Diagnostic Equipment
Market
Molecular Chlamydia Trachomatis (CT) & Neisseria
Gonorrhoeae (NG) Diagnostic Equipment Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Molecular Chlamydia Trachomatis (CT) & Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size and Growth
The Molecular Chlamydia Trachomatis (CT) & Neisseria Gonorrhoeae (NG)
Diagnostic Equipment market is experiencing significant growth due to increasing STIs, rapid testing advancements, and rising awareness. The market size is projected to reach USD 1.2 billion by 2028, driven by technological innovations and broader screening initiatives globally. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Cepheid
◍ Beckton Dickinson
◍ Gen Probe (Hologic)
◍ Qiagen
◍ Roche
◍ Bayer Healthcare
◍ Dako
◍ Abbott Laboratories
◍ Danaher
◍ Siemens
◍ Sysmex
◍ Grifols
◍ Biomérieux
The Molecular Chlamydia Trachomatis and Neisseria Gonorrhoeae diagnostic market features key players like Cepheid, Roche, and Abbott, leveraging innovative technologies to enhance testing accuracy and speed. Their contributions drive market growth through expanded product lines, improved diagnostics, and strategic partnerships. Revenue figures include:
- Roche: $63 billion (2022)
- Abbott: $43 billion (2022)
- Danaher: $31 billion (2022) Request Sample Report
Market Segmentation
By Application
Hospital
Research
Clinic
By Product
◍ Pcr
◍ In Situ Hybridization
◍ Chips And Microarrays
Others Request Sample Report
◍ Isothermal Nucleic Acid Amplification Technology (Inaat)
◍ Mass Spectrometry ◍ Sequencing ◍ Transcription Mediated Amplification
Market Growth
Request Sample Report
$ X Billion USD
